Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
60 hedge funds and large institutions have $32.8M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 6 closing their positions.
5,100% more call options, than puts
Call options by funds: $104K | Put options by funds: $2K
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
6% less funds holding
Funds holding: 64 → 60 (-4)
8% less capital invested
Capital invested by funds: $35.7M → $32.8M (-$2.89M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$835K |
| 2 |
Renaissance Technologies
New York
|
+$586K |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$483K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$237K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$131K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.29M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$243K |
| 3 |
Millennium Management
New York
|
-$134K |
| 4 |
Two Sigma Investments
New York
|
-$99.2K |
| 5 |
Goldman Sachs
New York
|
-$86.4K |
FRTX Hedge Fund Activity: Q1 2015 in Review
60 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q1 2015, worth a combined $32.8M — down 8.1% from $35.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FRTX and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 16 added.
The largest buyer was RA Capital Management, adding an estimated $835K. The largest seller was Great Point Partners, cutting an estimated $1.29M.
- 60 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q1 2015, down from 64 in Q4 2014.
- Funds reported $32.8M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q1 2015, down 8.1% quarter-over-quarter.
- 2 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q1 2015 and 6 closed out, a net change of -4 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q1 2015 was RA Capital Management, an estimated $835K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q1 2015 was Great Point Partners, an estimated $1.29M sold.
Based on aggregated 13F filings for Q1 2015.